Log In Get Started
Press Releases August 27, 2026 09:01 AM

GRI Bio Featured in "Why Now" On-Demand Video Webcast

GRI Bio featured in 'Why Now' on-demand video webcast to highlight its innovative therapies.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
GRI

GRI Bio, a biotechnology company listed on NASDAQ, announced its feature in the 'Why Now' on-demand video webcast, showcasing its work on developing therapies for inflammatory, fibrotic, and autoimmune diseases.

GRI Bio Featured in "Why Now" On-Demand Video Webcast
GRI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • GRI Bio is highlighted in a webcast focused on innovative biotechnology developments.
  • The company is advancing therapies targeting inflammatory, fibrotic, and autoimmune disorders.
  • The webcast aims to increase awareness and visibility of GRI Bio's therapeutic pipeline.

Video webcast now available here

LA JOLLA, CA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, fibrotic and autoimmune diseases, today announced that it is featured in a

Risks

  • Market and clinical development risks inherent in biotechnology and pharmaceutical industries.
  • Uncertainty over how much the webcast exposure will translate into investor interest or new partnerships.
  • The competitive landscape for therapies in inflammatory and autoimmune diseases is intense and evolving.

More from Press Releases

Coastal Community Bank Invests in Workforce Housing Through Koz Development's PNW Attainable Workforce Housing Fund Oct 9, 2026 Edible Garden Receives Preliminary Approval to Sell Tax Credits Through New Jersey Economic Development Authority (NJEDA) Program Oct 9, 2026 High Roller Technologies to Present at the 2026 ThinkEquity Conference Oct 9, 2026 SkinHealth Systems Announces Reverse Stock Split Oct 9, 2026 Gentherm Announces Date for 2026 Third Quarter News Release and Conference Call Oct 9, 2026